Listen to the CBC Radio Noon (88.5 FM) interviews on HIV, November 30, 2009:
Dr. Pant Pai (mp3)
Dr. Routy (mp3)
Dr. Falutz(mp3)
 |
On World AIDS Day, Tuesday December 1, 2009, we invited you to a Café Scientifique to learn about the progress that has been made in Canada and internationally in responding to this epidemic, and about the challenges that we face. The event was webcast live and videotaped. |
| Video links: Presentations |
|
 1. Introduction: Ms. Sue Smith, CBC |
 2. Dr. Nitika Pant Pai |
 3. Dr. Jean-Pierre Routy |
 4. Dr. Julian Falutz |
| Discussions |
|
 Q & A 1 |
 Q & A 2 |
 Q & A 3 |
 Q & A 4 |
Sue Smith, broadcaster,
host of Radio Noon CBC,
Montreal
Dr. Nitika Pant Pai M.D.,
Assistant professor of Medicine,
McGill University Division of Infectious Disease and Immunodeficiency
and Clinical Epidemiology Medical scientist
at the Infection and Immunity Axis at the
Research Institute, MUHC
Montreal
Dr. Jean-Pierre Routy M.D. ,
Division of Hematology and Immunodeficiency Service,
MUHC Researcher, Infection and Immunity Axis
at the Research Institute,
MUHC Associate Professor, McGill University
Dr. Julian Falutz M.D. ,
Director, HIV Metabolic Centre,
MUHC Immune Deficiency Treatment Centre
Senior Physician, Division of Geriatrics
Q & A 1
01. You said that as patients are living longer with HIV, they begin to develop complications. Are those caused by the virus, or could it be due to being on the medications for such a long period of time, (or both)?
02. How can you differentiate between whether it's the residual virus or the medication that is causing the problems?
03. Are any of you looking into doing further research relative to stigma, as it has a direct effect on prevention in many cultures? since on a social level it affects the availability of preventative measures?
04. We are looking for ways to prevent & control HIV, yet when a person is newly diagnosed, the medical team is not allowed to inform the person's partner of this diagnosis. What is your opinion on this?
Q & A 2
05. Will the saliva test that you mentioned ever be available in pharmacies for self-administration?
06. Do you find it frustrating that because of man-made barriers, your breakthroughs may not reach communities in need such as the African continent? Do you ever consider forming a non-profit NGO to help overcome this?
07. How much of the accelerated aging is due to an inflammatory response to immune activity?
08. If the therapeutic vaccine increases immune activity, is there a risk it could cause further accelerated aging?
Q & A 3
09. Est-ce que l'idée du vaccin serait de prendre un échantillion de toute la population de gens séropositifs pour augmenter le taux de succès?
10. Comment ça se fait que les gouvernements canadien et québécois s'interessent moindrement à la prevention du SIDA et du VIH quand ils sont responsables pour tant de morts chaque an?
11. When a needlestick injury occurs at the hospital, a drug can be given within 2hrs to prevent HIV infection. Is there any hope of extending that time period and making the drug more publicly available?
Q & A 4
12. Are we winning the battle against HIV/AIDS?